Lessons from a French collaborative case-control study in cystic fibrosis patients during the 2009 A/H1N1 influenza pandemy

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Bucher, Julie ^a   Boelle, Pierre Yves ^b   Hubert, Dominique ^c   Lebourgeois, Muriel ^a   Stremler, Nathalie ^d   Durieu, Isabelle ^e   Bremont, François ^f   Deneuville, Eric ^g   Delaisi, Bertrand ^h   Corvol, Harriet ⁱ   Bassinet, Laurence ^j   Grenet, Dominique ^k   Remus, Natacha ^j   Vodoff, Marie Véronique ^l   Boussaud, Véronique ^m   Troussier, Françoise ⁿ   Leruez Ville, Marianne ^a   Treluyer, Jean Marc ^o   Launay, Odile ^c   Sermet Gaudelus, Isabelle ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c Institut Cochin   (France)

^d TIMONE HOSPITAL   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f CHU PURPAN   (France)

^g SERVICE DE RHUMATOLOGIE   (France)

^h HÔPITAL ROBERT DEBRÉ   (France)

ⁱ ARMAND TROUSSEAU HOSPITAL   (France)

^j CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^k FOCH HOSPITAL   (France)

^l CENTRE HOSPITALIER DE MULHOUSE   (France)

^m HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁿ ANGERS UNIVERSITY HOSPITAL   (France)

^o GHU Necker Cochin   (France)

more..

Author keywords

A H1N1 influenza; Cystic fibrosis; Oseltamivir; Pandemic

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; OSELTAMIVIR; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CFTR PROTEIN, HUMAN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;

2009 H1N1 INFLUENZA; ADOLESCENT; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FRANCE; HUMAN; LUNG TRANSPLANTATION; MALE; NONINVASIVE VENTILATION; OXYGEN THERAPY; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY FAILURE; SPUTUM EXAMINATION; STAPHYLOCOCCUS INFECTION; VIRUS DETECTION; ADULT; CHILD; COMPLICATION; GENETICS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MUTATION; PANDEMIC; PRESCHOOL CHILD; PROSPECTIVE STUDY; PSEUDOMONAS INFECTIONS; SPUTUM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MUTATION; OSELTAMIVIR; PANDEMICS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM; YOUNG ADULT;

EID: 84957933313     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1352-2     Document Type: Article

References (34)

1. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med. 2005;352:1992-2001.
2. Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988;113:826-30.
3. Armstrong D, Grimwood K, Carlin JB, Carzino R, Hull J, Olinsky A, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol. 1998;26:371-9.
4. Conway SP, Simmonds EJ, Littlewood JM. Acute severe deterioration in cystic fibrosis associated with influenza A virus infection. Thorax. 1992;47:112-4.
5. Esther Jr CR, Lin FC, Kerr A, Miller MB, Gilligan PH. Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis. Pediatr Pulmonol. 2014;49:926-31.
6. Etherington C, Naseer R, Conway SP, Whitaker P, Denton M, Peckham DG. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros. 2014;13:49-55.
7. Flight WG, Bright-Thomas RJ, Tilston P, Mutton KJ, Guiver M, Morris J, et al. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax. 2014;69:247-53.
8. Goffard A, Lambert V, Salleron J, Herwegh S, Engelmann I, Pinel C, et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J Clin Virol. 2014;60:147-53.
9. Hoek RA, Paats MS, Pas SD, Bakker M, Hoogsteden HC, Boucher CA, et al. Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis. 2013;45:65-9.
10. Robinson KM, Kolls JK, Alcorn JF. The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol. 2015;34C:59-67 [Epub ahead of print].
11. Ortiz JR, Neuzil KM, Victor JC, Wald A, Aitken ML, Goss CH. Influenza-associated cystic fibrosis pulmonary exacerbations. Chest. 2010;137:852-60.
12. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child. 1995;73:117-20.
13. van Ewijk BE, van der Zalm MM, Wolfs TF, Fleer A, Kimpen JL, Wilbrink B, et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics. 2008;122:1171-6.
14. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med. 2012;18:509-19.
15. Viviani L, Assael BM, Kerem E. Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J Cyst Fibros. 2011;10:370-6.
16. Ministère de la Santé et des Sports. Grippe: information aux professionnels. Prise en charge de vos patients (September 17th, 2009): http://www.sante.gouv.fr/prise-en-charge-de-vos-patients,3247.html. Acccessed date: 20 January 2016
17. Bilton D, Canny G, Conway S, Dumcius S, Hjelte L, Proesmans M, et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros. 2011;10 Suppl 2:S79-81.
18. Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, et al. Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Orphanet journal of rare diseases. 2012;7:64.
19. Brammer L, Blanton L, Epperson S, Mustaquim D, Bishop A, Kniss K, et al. Surveillance for Influenza during the 2009 Influenza A (H1N1) Pandemic-United States, April 2009-March 2010. Clin Infect Dis. 2011;52:S27-35.
20. Vaux S, Brouard C, Fuhrman C, Turbelin C, Cohen JM, Valette M, et al. Dynamics and impact of the A(H1N1) 2009 epidemic in metropolitan France, 2009-2010. Bull Epid Hebd. 2010;24-26.
21. Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, et al. Factors associated with humoral immune response to pandemicA/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 2014;32:4515-21.
22. Colombo C, Battezzati PM, Lucidi V, Magazzù G, Motta V, Alicandro G, et al. Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax. 2011;66:260-1.
23. France MW, Tai S, Masel PJ, Moore VL, McMahon TL, Ritchie AJ, et al. The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulm Med. 2010;10:8.
24. Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, Honeybourne D. Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax. 2011;66:259.
25. Whitaker P, Etherington C, Denton M, Conway S, Peckham D. A/H1N1 flu pandemic. A/H1N1 and other viruses affecting cystic fibrosis. BMJ. 2009;339:b3958.
26. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza,Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708-19.
27. Lemaitre M, Carrat F. Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis. 2010;10:162.
28. Sehgal N, Woodhead M. Predicting the unpredictable: is it possible clinically to separate H1N1 from non-H1N1 community-acquired pneumonia? Thorax. 2011;66:187-8.
29. Yamamoto T, Ihashi M, Mizoguchi Y, Kaneno H, Yamamoto K, Inoue Y, et al. Early therapy with neuraminidase inhibitors for influenza A (H1N1) pdm 2009 infection. Pediatr Int. 2013;55:714-21.
30. Tautenberg JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499-522.
31. Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol. 2014;14:315-28.
32. Chattoraj SS, Ganesan S, Jones AM, Helm JM, Comstock AT, Bright-Thomas R, et al. Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax. 2011;66(4):333-9.
33. Petersen NT, Hoiby N, Mordhorst CH, Lind K, Flensborg EW, Bruun B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasmapossible synergism with Pseudomonas aeruginosa. Acta Paediatr Scand. 1981;70:623-8.
34. WHO (2013) Epidemiological and virological situation update of the 2012/2013 influenza season in the WHO European Region. WHO Europe Publications. Available: http://www.euro.who.int/__data/assets/pdf_file/0010/184690/Epi-and-virological-update-of-the-2012-13-influenza-season-in-the-WHO-EURO-EuroFlu-data-week-40,2012-to-week-04,2013.pdf.